ASHPOfficial

In this episode, our content matter experts describe how they identified and procured the necessary technology to facilitate remote work for medication history technicians. This included developing procedures for contacting patients/caregivers remotely to conduct medication history interviews, and training technicians on new technology and workflow and metrics related to the services. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The draft revision of the ASHP Accreditation Standard for Postgraduate Residency Programs was released for comment on 12/9/2021. One notable addition to the harmonized draft standards is the focus on resident wellbeing. This podcast is intended to highlight how some programs have worked to incorporate residency wellbeing into their program structure and how that could positively impact residency training. 

 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will cover current challenges and best practices for hospitals and health systems looking to maintain multistate pharmacy and pharmacy workforce compliance.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Overprescribing of opioids led to the development of the CDC guidelines for chronic pain which recommended opioid taper in patients when risk outweighed benefit, especially in patients receiving high dose opioids, in order to decrease risk of opioid-related adverse reactions and overdose potential.  However, increased risk of harm has been reported in those who may have had opioids tapered inappropriately.  This podcast will highlight the process for opioid tapering based on length of opioid therapy and potential harm from opioid use.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, pharmacy technicians discuss the Standardize 4 Safety initiative and how it impacts the role of the technician in medication preparation and patient safety.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The CDC has provided a lot of guidance surrounding COVID-19 vaccine boosters and there are several vaccine manufacturers of these vaccines. How do we make sense of this information to ensure patients receive appropriate, evidence-based protection? This podcast will describe supplementary guidance for mixing and matching COVID-19 vaccine boosters by evaluating the literature and also reviewing current CDC recommendations. 

Due to ongoing updates, please see the CDC’s COVID-19 Vaccine Interim Immunization Schedule for Ages 6 Months and Older here: https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-immunization-schedule-ages-6months-older.pdf  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Nilay Shah and Dr. Eric Tichy discuss the AJHP Special Feature, “National trends in prescription drug expenditures and projections for 2022,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, our pharmacists who practice in small and rural hospital share best practices for engaging and training pharmacists to use video conferencing technology, identify resources and strategies for developing telepharmacy services and how telepharmacy post COVID can advance pharmacy practice and improve patient care. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Listeners will be introduced to the background and purpose of the Specialty Pharmacy Outcomes Literature Library, an exciting new resource for ASHP members. This podcast will also discuss how best to utilize this resource as members set out to perform their own outcomes projects.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this first of a series, Vicki Basalyga, Director of Member Relations at ASHP and ASHP representative for the Navigators, sits down with the leaders of the group to discuss their mission, vision and the goals of this group as they relate to public health.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.